ARCHIVES

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

This article is from The Cancer Letter archive.

Vol. 14 No. 37 | September 23, 1988

Download PDF Visit The Full Archive

Related Articles

DCPC Board Objects To Cutting Grants Each Award Year

February 17, 1989

NCI Encourages New Regional Cooperative Groups

November 19, 1976

Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers

January 29, 1993

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting.

September 9, 2005